Finland· FI-REL-REL2360

Tyrazol

A carbimazole product containing carbimazole, registered in Finland by Orion Corporation. The same ATC class is registered in 8 of our 19 countries.

ATC H03BB01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTyrazolATCH03BB01REGISTER NO.FI-REL-REL2360PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Carbimazole is registered in 8 of 19 countries.

Countries holding a registration under ATC H03BB01 (carbimazole), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 4 of them publish a price we can compare per daily dose

Carbimazole · ATC H03BB01

8 / 19 countries

  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of carbimazole costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.15 in France to $0.94 in Switzerland — a ×6.3 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Carbimazole · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$0.94
  • FR France$0.15
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Carbimazole
Manufacturer
Orion Corporation
Country
Finland (FI)
ATC code
H03BB01
ATC class
Carbimazole
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carbimazole in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carbimazole products

Authorised across Europe · EMA

The same active substance is authorised in 11 EEA countries. Names it is sold under:

  • Cyprus · Carbimazole Remedica
  • Germany · Carbimazol 1 A Pharma, Carbimazol Aristo
  • Denmark · Neo-Mercazole
  • Spain · Neo-Tomizol
  • France · Neo-Mercazole
  • United Kingdom (Northern Ireland) · Carbimazole, Carbimazole Activase Pharmaceuticals
  • Greece · Thyrostat
  • Ireland · Carbimazole Essential Healthcare, Carbimazole Renata Pharmaceuticals (Ireland)
  • Malta · Carbimazole Remedica, Carbimazole Renata Pharmaceuticals (Ireland)
  • Norway · Neo-Mercazole
  • Portugal · Carbimazole Renata, Carbimazole Renata 20 Mg Comprimidos

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f3d63bdf-2bc8-4a10-8778-16df1b5106a6
GET /v1/drugs/f3d63bdf-2bc8-4a10-8778-16df1b5106a6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "15",
  "form": "tabletti",
  "route": "Suun kautta",
  "ddd_unit": "mg",
  "strength": "5 mg",
  "atc_label": "karbimatsoli",
  "ma_number": "9788",
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": null,
  "fimea_rel_id": "REL2360",
  "authorised_at": "1988-10-26"
}

See everything about carbimazole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.